189 related articles for article (PubMed ID: 12496219)
1. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.
Gottstein R; Cooke RW
Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F6-10. PubMed ID: 12496219
[TBL] [Abstract][Full Text] [Related]
2. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
Li ZH; Wang J; Chen C
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
[TBL] [Abstract][Full Text] [Related]
3. Should intravenous immunoglobulin be used in infants with isoimmune haemolytic disease due to ABO incompatibility?
Keir AK; Dunn M; Callum J
J Paediatr Child Health; 2013 Dec; 49(12):1072-8. PubMed ID: 24325716
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis.
Louis D; More K; Oberoi S; Shah PS
Arch Dis Child Fetal Neonatal Ed; 2014 Jul; 99(4):F325-31. PubMed ID: 24514437
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates.
Alcock GS; Liley H
Cochrane Database Syst Rev; 2002; (3):CD003313. PubMed ID: 12137687
[TBL] [Abstract][Full Text] [Related]
6. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease.
Voto LS; Sexer H; Ferreiro G; Tavosnanska J; Orti J; Mathet ER; Margulies M; Margulies M
J Perinat Med; 1995; 23(6):443-51. PubMed ID: 8904473
[TBL] [Abstract][Full Text] [Related]
7. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease.
Rübo J; Albrecht K; Lasch P; Laufkötter E; Leititis J; Marsan D; Niemeyer B; Roesler J; Roll C; Roth B
J Pediatr; 1992 Jul; 121(1):93-7. PubMed ID: 1306646
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin to treat neonatal alloimmune haemolytic disease.
Corvaglia L; Legnani E; Galletti S; Arcuri S; Aceti A; Faldella G
J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2782-5. PubMed ID: 22882154
[TBL] [Abstract][Full Text] [Related]
10. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.
Elalfy MS; Elbarbary NS; Abaza HW
Eur J Pediatr; 2011 Apr; 170(4):461-7. PubMed ID: 20924607
[TBL] [Abstract][Full Text] [Related]
11. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice.
Alpay F; Sarici SU; Okutan V; Erdem G; Ozcan O; Gökçay E
Acta Paediatr; 1999 Feb; 88(2):216-9. PubMed ID: 10102158
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
Nasseri F; Mamouri GA; Babaei H
Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME
Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn.
Onesimo R; Rizzo D; Ruggiero A; Valentini P
J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1059-61. PubMed ID: 20092394
[TBL] [Abstract][Full Text] [Related]
15. International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn.
Lieberman L; Lopriore E; Baker JM; Bercovitz RS; Christensen RD; Crighton G; Delaney M; Goel R; Hendrickson JE; Keir A; Landry D; La Rocca U; Lemyre B; Maier RF; Muniz-Diaz E; Nahirniak S; New HV; Pavenski K; Dos Santos MCP; Ramsey G; Shehata N;
Br J Haematol; 2022 Jul; 198(1):183-195. PubMed ID: 35415922
[TBL] [Abstract][Full Text] [Related]
16. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease.
Dağoğlu T; Ovali F; Samanci N; Bengisu E
J Int Med Res; 1995; 23(4):264-71. PubMed ID: 7589769
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of two dose regimes of intravenous immunoglobulin in Rh hemolytic disease of newborn--a randomized controlled trial.
Girish G; Chawla D; Agarwal R; Paul VK; Deorari AK
Indian Pediatr; 2008 Aug; 45(8):653-9. PubMed ID: 18723908
[TBL] [Abstract][Full Text] [Related]
18. Use of intravenous immunoglobulin in neonates with haemolytic disease and immune thrombocytopenia.
Marković-Sovtić G; Janković B; Rakonjac Z; Martić J; Pejić K
Vojnosanit Pregl; 2013 Nov; 70(11):1029-33. PubMed ID: 24397198
[TBL] [Abstract][Full Text] [Related]
19. Single versus multiple dose intravenous immunoglobulin in combination with LED phototherapy in the treatment of ABO hemolytic disease in neonates.
Demirel G; Akar M; Celik IH; Erdeve O; Uras N; Oguz SS; Dilmen U
Int J Hematol; 2011 Jun; 93(6):700-703. PubMed ID: 21617887
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
